Workflow
ZACKS
icon
Search documents
Consolidated Edison (ED) Q4 Earnings and Revenues Top Estimates
ZACKS· 2026-02-19 23:50
Consolidated Edison (ED) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +5.59%. A quarter ago, it was expected that this utility would post earnings of $1.76 per share when it actually produced earnings of $1.9, delivering a surprise of +7.95%.Over the last four quarters, the company ...
Why the Market Dipped But Axon Enterprise (AXON) Gained Today
ZACKS· 2026-02-19 23:50
Axon Enterprise (AXON) closed at $441.12 in the latest trading session, marking a +2.56% move from the prior day. The stock's change was more than the S&P 500's daily loss of 0.28%. Elsewhere, the Dow saw a downswing of 0.54%, while the tech-heavy Nasdaq depreciated by 0.31%. Shares of the maker of stun guns and body cameras witnessed a loss of 29.52% over the previous month, trailing the performance of the Aerospace sector with its loss of 2.29%, and the S&P 500's loss of 0.76%.The investment community wil ...
Pulse Biosciences, Inc (PLSE) Reports Q4 Loss, Beats Revenue Estimates
ZACKS· 2026-02-19 23:46
Financial Performance - Pulse Biosciences reported a quarterly loss of $0.26 per share, better than the Zacks Consensus Estimate of a loss of $0.32, representing an earnings surprise of +18.75% [1] - The company posted revenues of $0.26 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 5.60%, compared to zero revenues a year ago [2] - The current consensus EPS estimate for the upcoming quarter is -$0.37 on $0.5 million in revenues, and for the current fiscal year, it is -$1.66 on $3.75 million in revenues [7] Stock Performance - Pulse Biosciences shares have increased by approximately 85.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6] Industry Outlook - The Medical - Instruments industry, to which Pulse Biosciences belongs, is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable outlook [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]
AXT (AXTI) Reports Q4 Loss, Misses Revenue Estimates
ZACKS· 2026-02-19 23:46
分组1 - AXT reported a quarterly loss of $0.05 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.04, representing an earnings surprise of -15.47% [1] - The company posted revenues of $23.04 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 10.14%, compared to year-ago revenues of $25.1 million [2] - AXT shares have increased by approximately 44% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] 分组2 - The earnings outlook for AXT is uncertain, with current consensus EPS estimates of -$0.04 on $26.69 million in revenues for the coming quarter and -$0.01 on $122.53 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Electronics - Semiconductors is currently in the top 35% of over 250 Zacks industries, indicating a favorable industry outlook [8] - AXT has a Zacks Rank of 4 (Sell), suggesting that the stock is expected to underperform the market in the near future due to unfavorable estimate revisions [6]
RE/MAX (RMAX) Tops Q4 Earnings Estimates
ZACKS· 2026-02-19 23:46
分组1 - RE/MAX reported quarterly earnings of $0.3 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, with an earnings surprise of +7.14% [1] - The company posted revenues of $71.14 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 0.15%, and a decrease from year-ago revenues of $72.47 million [2] - Over the last four quarters, RE/MAX has surpassed consensus EPS estimates four times but has only topped consensus revenue estimates once [2] 分组2 - The stock has underperformed, losing about 10% since the beginning of the year, while the S&P 500 has gained 0.5% [3] - The current consensus EPS estimate for the coming quarter is $0.20 on revenues of $76.55 million, and for the current fiscal year, it is $1.26 on revenues of $296.19 million [7] - The Zacks Industry Rank for Real Estate - Operations is in the bottom 39% of over 250 Zacks industries, indicating potential challenges for stock performance [8]
Select Medical (SEM) Q4 Earnings Miss Estimates
ZACKS· 2026-02-19 23:46
Select Medical (SEM) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -31.57%. A quarter ago, it was expected that this hospital and rehabilitation center operator would post earnings of $0.18 per share when it actually produced earnings of $0.23, delivering a surprise of +27.78%.Over ...
WillScot (WSC) Misses Q4 Earnings Estimates
ZACKS· 2026-02-19 23:46
WillScot (WSC) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.49 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.91%. A quarter ago, it was expected that this maker of portable classrooms, mobile offices and storage units would post earnings of $0.29 per share when it actually produced earnings of $0.3, delivering a surprise of + ...
DocuSign (DOCU) Suffers a Larger Drop Than the General Market: Key Insights
ZACKS· 2026-02-19 23:46
Company Performance - DocuSign (DOCU) closed at $44.13, reflecting a -1.54% change from the previous day's closing price, underperforming the S&P 500's daily loss of 0.28% [1] - Prior to the recent trading session, DocuSign shares had decreased by 20.01%, significantly lagging behind the Computer and Technology sector's loss of 3.36% and the S&P 500's loss of 0.76% [1] Financial Projections - The upcoming earnings per share (EPS) for DocuSign is projected to be $0.95, indicating a 10.47% increase from the same quarter last year [2] - Revenue is expected to reach $828.2 million, representing a 6.69% increase compared to the year-ago quarter [2] - For the entire fiscal year, earnings are projected at $3.79 per share and revenue at $3.21 billion, reflecting changes of +6.76% and +7.86% respectively from the prior year [3] Analyst Estimates and Valuation - Recent changes to analyst estimates for DocuSign suggest confidence in the company's business performance and profit potential [3] - The Zacks Rank system, which incorporates estimate changes, currently ranks DocuSign as 2 (Buy) [5] - DocuSign's Forward P/E ratio stands at 10.77, indicating a discount compared to the industry average Forward P/E of 19.62 [5] - The company has a PEG ratio of 0.75, lower than the average PEG ratio of 1.1 for the Internet - Software industry [6] Industry Context - The Internet - Software industry, part of the Computer and Technology sector, holds a Zacks Industry Rank of 88, placing it in the top 36% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]
Here's Why Workday (WDAY) Fell More Than Broader Market
ZACKS· 2026-02-19 23:46
In the latest trading session, Workday (WDAY) closed at $140.02, marking a -1.83% move from the previous day. The stock's change was less than the S&P 500's daily loss of 0.28%. Elsewhere, the Dow lost 0.54%, while the tech-heavy Nasdaq lost 0.31%. Prior to today's trading, shares of the maker of human resources software had lost 22.23% lagged the Computer and Technology sector's loss of 3.36% and the S&P 500's loss of 0.76%.The upcoming earnings release of Workday will be of great interest to investors. Th ...
iRhythm Holdings, Inc. (IRTC) Q4 Earnings and Revenues Beat Estimates
ZACKS· 2026-02-19 23:40
iRhythm Holdings, Inc. (IRTC) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.01 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +1,484.70%. A quarter ago, it was expected that this company would post a loss of $0.36 per share when it actually produced a loss of $0.06, delivering a surprise of +83.33%.Over the last four quarters, the ...